294 related articles for article (PubMed ID: 23443492)
1. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?
Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS
Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492
[TBL] [Abstract][Full Text] [Related]
2. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
[TBL] [Abstract][Full Text] [Related]
3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
4. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
6. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
8. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
[TBL] [Abstract][Full Text] [Related]
10. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
11. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
[TBL] [Abstract][Full Text] [Related]
12. [Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials].
Saigusa H; Niimi S; Saigusa U; Yagi T
Nihon Jibiinkoka Gakkai Kaiho; 2001 Oct; 104(10):1025-33. PubMed ID: 11710151
[TBL] [Abstract][Full Text] [Related]
13. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
[TBL] [Abstract][Full Text] [Related]
14. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
15. A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.
Adachi K; Furuta K; Miwa H; Oshima T; Miki M; Komazawa Y; Iwakiri K; Furuta T; Koike T; Shimatani T; Kinoshita Y
Dig Dis Sci; 2012 Jun; 57(6):1609-17. PubMed ID: 22367114
[TBL] [Abstract][Full Text] [Related]
16. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists.
Mearin F; Ponce J; Ponce M; Balboa A; González MA; Zapardiel J
World J Gastroenterol; 2012 Sep; 18(35):4885-91. PubMed ID: 23002360
[TBL] [Abstract][Full Text] [Related]
18. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
Roorda AK; Marcus SN; Triadafilopoulos G
Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of esophagogastroduodenoscopy in changing treatment outcome in refractory gastro-esophageal reflux disease.
Kwak YE; Saleh A; Abdelwahed A; Sanchez M; Masoud A
Scand J Gastroenterol; 2022 Jan; 57(1):124-130. PubMed ID: 34669534
[TBL] [Abstract][Full Text] [Related]
20. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]